FierceBiotech4h
Chutes & Ladders—Amylyx preps for GLP-1 launch with new CCO
Dan Monahan, the exec who led Otsuka’s commercialization of Rexulti and Abilify Maintena, is taking command of the launch of ...
FiercePharma4d
Amylyx names chief commercial officer as GLP-1 receptor antagonist launch plans start ramping up
Amylyx Pharmaceuticals has named Dan Monahan as chief commercial officer, positioning an exec who led the U.S.
ENDPOINTS NEWS4h
John Maraganore turns to ex-Al­ny­lam col­league to lead his lat­est RNAi bet; Amy­lyx names com­mer­cial chief
City Therapeutics broke cover in October with a $135 million Series A and the opportunity for executive chairman John ...
BioSpace11h
HEALEY ALS Trial Serves Up More Disappointment as Denali, AbbVie/Calico Fail
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...
Why Is Amylyx Pharmaceuticals (AMLX) Among the Best Biotech Penny Stocks to Invest in Now?
We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...
Joplin Globe4d
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the Company’s Leadership ...
Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares are being ...